Cargando…

Antifungal Resistance and Predictors of Response in Patients with Hematologic Malignancy

BACKGROUND: Invasive aspergillosis (IA) causes significant morbidity and mortality in patients with hematologic malignancies (HM). Azole resistance has emerged as a therapeutic challenge in managing IA. The aim of this study was to investigate Aspergillus susceptibility to antifungals over the past...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wey, Shiuan (Shannon), Kriengkauykiat, Jane, Chan, Ayla, Tegtmeier, Bernard, Ito, James, Dadwal, Sanjeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632207/ http://dx.doi.org/10.1093/ofid/ofx163.036

Ejemplares similares

1760. Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Hematologic Malignancies and Hematopoietic Cell Transplant
por: Ross, Justine Abella, et al.
Publicado: (2019)

Epidemiology and treatment approaches in management of invasive fungal infections
por: Kriengkauykiat, Jane, et al.
Publicado: (2011)

2617. Antiviral usage for herpes simplex virus (HSV) detected in bronchoalveolar lavage fluid (BALF) by polymerase chain reaction (PCR) in hematologic malignancy (HM) and solid organ malignancy (SOM) patients with pulmonary infiltrates; impact of infectious disease consultation (IDC) on antiviral stewardship
por: Fu, Cynthia, et al.
Publicado: (2023)

1556. Infectious Disease Complications with Use of Checkpoint Inhibitors in Solid Organ Malignancies
por: Komoda, Kellie, et al.
Publicado: (2018)

Chronic Leptomeningitis and Spinal Intradural Mass Secondary to Alternaria Infection in a Patient with Ventriculoperitoneal Shunt
por: Dadwal, Sanjeet S., et al.
Publicado: (2016)

The COVID‐19 infection control response at a large stand‐alone comprehensive cancer center in Los Angeles County
por: Battey, Hannah, et al.
Publicado: (2022)

755. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
por: Almutairy, Reem F, et al.
Publicado: (2020)

1251. Strengthening Antimicrobial Stewardship Programs through Public Health Support
por: Kriengkauykiat, Jane, et al.
Publicado: (2023)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

The Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic Malignancy
por: Lee, Rachael A, et al.
Publicado: (2017)

Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States
por: Barreto, Jason N, et al.
Publicado: (2022)

1250. Association Between Antimicrobial Stewardship Resources and Practices Reported by California Hospitals in the National Healthcare Safety Network Annual Survey and California Department of Public Health Antimicrobial Stewardship Program Honor Roll Designation
por: Brenes, Lizette, et al.
Publicado: (2023)

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies
por: Gamaletsou, Maria N., et al.
Publicado: (2018)

Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells
por: Pan, Jingxuan
Publicado: (2012)

755. Predictors of Mortality in Invasive Mold Infections Among Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients
por: Gupta, Aanchal, et al.
Publicado: (2022)

Predictors of intensive care unit admission in patients with hematologic malignancy
por: Vijenthira, Abi, et al.
Publicado: (2020)

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China
por: Yuan, Wei, et al.
Publicado: (2016)

2120. Respiratory Viral Infections in Patients with Hematologic Malignancies
por: Cardenas, Jorge Luis, et al.
Publicado: (2022)

Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy
por: Mortimer, Joanne, et al.
Publicado: (2014)

2473. Rates of Antibiotic Resistant Infections in Hospitalized Patients with Hematologic and Non-Hematologic Cancers, 2019
por: McCarthy, Natalie, et al.
Publicado: (2023)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

2113. Infectious endocarditis in patients with hematologic malignancy at the University of Wisconsin
por: Scolarici, Michael J, et al.
Publicado: (2022)

Use of antifungal drugs in hematology
por: Nucci, Marcio
Publicado: (2012)

Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012)

Infectious complications of immune checkpoint inhibitors in solid organ malignancies
por: Ross, Justine Abella, et al.
Publicado: (2021)

358. Surveillance of Activity of Antifungals: Data from the Analysis of Resistance in Antifungals (ARIA) 2020 Study
por: Hawser, Stephen, et al.
Publicado: (2022)

4164 Body mass index, not chemotherapy is the major predictor of insulin resistance in patients with hematological malignancies
por: Sahinoz, Melis, et al.
Publicado: (2020)

Drug Resistance in Hematological Malignancies
por: Auberger, Patrick, et al.
Publicado: (2020)

169. Multidrug-Resistant Bacteria Are Common Cause of Neutropenic Fever and Increase Mortality Among Patients with Hematologic Malignancies in Uganda
por: Lubwama, Margaret, et al.
Publicado: (2019)

1730. Invasive Fusarium Species in Mayo Clinic Patients with Hematologic Malignancies
por: Harris, Courtney, et al.
Publicado: (2019)

2567. Diagnosis of Invasive Aspergillosis in Hematological Malignancy Patients Receiving Mold-Active Antifungals: Performance of Interleukin-6 and -8, Asp LFD, and Aspergillus PCR in Same-day Blood and Bronchoalveolar Lavage Fluid Samples
por: Hoenigl, Martin, et al.
Publicado: (2018)

2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study
por: Seidel, Danila, et al.
Publicado: (2019)

Bullous pyoderma gangrenosum as a predictor of hematological malignancies
por: Vacas, Aldana Soledad, et al.
Publicado: (2018)

The importance of genomic predictors for clinical outcome of hematological malignancies
por: Chen, Cunte, et al.
Publicado: (2021)

Prevalence and predictors of solid or hematological malignancies in a monocentric cohort of HIV patients from central Italy
por: Mazzotta, E, et al.
Publicado: (2012)

1535. Utility of CT Abdomen in Evaluation of Neutropenic Fever in Patients with Hematological Malignancies
por: Al-Ward, Ruaa, et al.
Publicado: (2018)

2596. Invasive Fungal Disease in Patients with GATA2 Variant Hematologic Malignancy
por: Bold, Tyler D, et al.
Publicado: (2019)

2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies
por: Aleissa, Muneerah M, et al.
Publicado: (2023)

1786. Characterizing Antibiotic Use in Patients with Hematologic and Oncologic Malignancies Transitioned to Comfort Measures Only (CMO) During Hospital Admission
por: Chan, Michelle, et al.
Publicado: (2022)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p4lsd8h1k136f61atckuo6e0qi